BioLegend

BioLegend
Company typeSubsidiary
IndustryBiotechnology
Founded2002
Headquarters
San Diego, California
,
U.S.
Area served
Worldwide
Key people
Gene Lay, D.V.M., Founder and CEO
ProductsAntibodies, ELISA Kits and Sets, Recombinant Proteins, Custom Assay Development, Buffers and Solutions
ParentRevvity
Websitebiolegend.com

BioLegend is a global developer and manufacturer of antibodies and reagents used in biomedical research located in San Diego, California.[1] It was incorporated in June 2002 and has since expanded to include BioLegend Japan KK, where it is partnered with Tomy Digital Biology Co., Ltd. in Tokyo, BioLegend Europe in the United Kingdom, BioLegend GmbH in Germany, and BioLegend UK Ltd in the United Kingdom. In July 2021, BioLegend was acquired by PerkinElmer for $5.25 billion and now operates as Revvity.[2] BioLegend manufactures products in the areas of neuroscience, cell immunophenotyping, cytokines and chemokines, adhesion, cancer research, T regulatory cells, stem cells, innate immunity, cell-cycle analysis, apoptosis, and modification-specific antibodies. Reagents are created for use in flow cytometry, proteogenomics, ELISA, immunoprecipitation, Western blotting, immunofluorescence microscopy, immunohistochemistry, and in vitro or in vivo functional assays.[3]

  1. ^ "Antibodies and conjugates for biomedical research: News from Cambridge BioScience". Archived from the original on 2011-07-18. Retrieved 2009-07-21.
  2. ^ "PerkinElmer to Acquire Antibody and Reagent Leader BioLegend". BioSpace. 26 July 2021. Retrieved 20 March 2024.
  3. ^ "PerkinElmer and BioLegend Announce Custom Immunoassay Development Collaboration for Drug Discovery Research". Archived from the original on 2012-03-13. Retrieved 2009-07-21.